[Plasma iron turnover before and following cytostatic therapy and its signifiance as indicator of tumor activity].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007501:Iron / Q000097:blood* / Q000378:metabolism; D007503:Iron Isotopes; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D007503:Iron Isotopes; D007501:Iron
Der Plasmaeisenumsatz vor und nach cytostatischer Therapie und seine Bedeutung als Indicator der Tumoraktivität.